Workflow
国家标准物质
icon
Search documents
我国新批准发布891项国家标准物质
Ren Min Ri Bao· 2025-10-12 22:10
Core Insights - The National Market Regulation Administration reported that in the first three quarters, China approved 891 new national standard substances, representing a year-on-year increase of 75.7% [1] - Among these, 48 are national first-level standard substances, accounting for 5.4% of the total, with a year-on-year growth of 23.1% [1] - The remaining 843 are national second-level standard substances, making up 94.6% of the total, with a significant year-on-year increase of 80.1% [1] - Standard substances are essential for conducting chemical and biological testing activities and are a key element in the construction of national measurement capabilities [1] - As of now, the National Market Regulation Administration has cumulatively approved 19,349 national standard substances [1]
前三季度 我国新批准发布891项国家标准物质
Ren Min Ri Bao· 2025-10-12 21:55
Core Insights - The National Market Regulation Administration reported that in the first three quarters, China approved 891 new national standard substances, representing a year-on-year increase of 75.7% [1] - Among these, 48 are national first-level standard substances, accounting for 5.4% of the total, with a year-on-year growth of 23.1% [1] - The remaining 843 are national second-level standard substances, making up 94.6% of the total, with a significant year-on-year increase of 80.1% [1] - Standard substances are essential for conducting chemical and biological testing activities and are a key element in the construction of national measurement capabilities [1] - As of now, the National Market Regulation Administration has cumulatively approved 19,349 national standard substances [1]
前三季度我国新批准发布891项国家标准物
Yang Shi Wang· 2025-10-12 01:51
Group 1 - The core viewpoint of the articles highlights a significant increase in the approval and release of national standard substances in China, with a total of 891 items approved in the first three quarters, representing a year-on-year growth of 75.7% [1][2] - The rapid growth in the approval of standard substances is attributed to the enhancement of production capabilities by operating entities and the establishment of a mechanism for quick market response, which are seen as the core drivers of high-quality development in national standard substances [1] - In terms of specific fields, 353 items related to environmental monitoring were approved, accounting for 39.6% of the total, with a remarkable year-on-year growth of 100.6%, although there is a need for further quality improvement [1] Group 2 - Among the approved standard substances, 53.9% pertain to food safety, with specific standards aiding in the regulation and quality testing of infant food products and dairy products [1] - Enterprises submitted 655 items for approval, making up 73.5% of the total, with a year-on-year growth of 93.2%, while research institutions submitted 236 items, accounting for 26.5% and growing by 47.8% [2] - The total number of national standard substances approved to date stands at 19,349, with China's international metrology recognition capabilities remaining in the leading tier globally [2]
超1.9万项国家标准物质获批发布
Ren Min Ri Bao· 2025-08-08 20:04
Core Insights - The National Market Supervision Administration of China has approved a total of 19,007 national standard substances, maintaining a leading position in international metrology recognition [1] - From January to July, 549 new national standard substances were approved, representing a year-on-year increase of 56%, indicating strong demand in both production and research [1] Traditional Fields - Traditional sectors remain the "basic plate" for standard substances, with 205 approved for environmental monitoring, accounting for 37.3% of the total, and a year-on-year growth of 64% [1] Emerging Fields - In high-end biomedicine and new semiconductor manufacturing, the development of standard substances is still in the "quantity and quality climbing" stage, addressing key metrology challenges in industrial development [1] Production and Research Dynamics - Companies produced 401 standard substances, making up 73% of the total, with a year-on-year increase of 68.5%, all classified as national secondary standard substances [1] - Research institutions developed 148 standard substances, accounting for 27% of the total, with a year-on-year growth of 29.8%, including 31 national primary and 117 secondary standard substances [1] - Research institutions focus on high-end measurement needs, with national primary standard substances primarily produced by these entities, achieving domestic and even international advanced technical standards [1]
国家标准物质:1-7月新增549项,多领域发展向好
Sou Hu Cai Jing· 2025-08-07 03:17
本文由 AI 算法生成,仅作参考,不涉投资建议,使用风险自担 【市场监管总局:我国标准物质国际计量互认能力居全球第一梯队】近日,市场监管总局公布数据,截 至目前累计批准发布国家标准物质19007项,我国标准物质国际计量互认能力稳居全球第一梯队。1 - 7 月新批准发布549项,同比增长56%,研制生产供需两旺。 标准物质应用领域双轮驱动,传统依然 是"基本盘"。1 - 7月环境监测领域批准发布205项,占比37.3%,同比增长64%。新兴领域虽处"量质爬 升"阶段,但能解决关键计量技术难题,如"突变MSTN基因产量性状改良肉牛质粒DNA标准物质"等。 研制生产呈现企业与科研互补格局。1 - 7月企业研制401项,占比73%,同比增68.5%,均为国家二级; 科研单位研制148项,占比27%,同比增29.8%,含一级31项、二级117项,聚焦高端测量需求。 华北地 区集中度高,显现集群效应。1 - 7月批准发布244项,占比44.4%,同比增165.2%。北京数量居前,形成 区域特色。科研单位和企业数量相当,立足优势提升质与量。 市场监管总局将加强能力建设,推动相 关标准物质研制生产,为高质量发展提供计量支撑。 ...
国家标准物质:1 - 7月新批549项,多领域发展向好
Sou Hu Cai Jing· 2025-08-07 03:11
Core Insights - The National Market Regulation Administration has reported that China's international measurement recognition capability for standard substances ranks among the top tier globally [1] - As of July, a total of 19,007 national standard substances have been approved and released, with 549 new approvals in the first seven months of the year, representing a 56% year-on-year increase [1] Summary by Categories Standard Substance Development - The application of standard substances is driven by both traditional and emerging fields, with traditional sectors serving as the "basic plate" [1] - In the environmental monitoring sector, 205 new standard substances were approved from January to July, accounting for 37.3% of the total, with a year-on-year increase of 64% [1] Production and Research - The production of standard substances shows a complementary pattern, with enterprises producing 401 items (73% of total) and research institutions producing 148 items (27% of total) in the first seven months, reflecting increases of 68.5% and 29.8% respectively [1] - Research institutions focus on high-end measurement needs and are the main developers of national first-level standard substances [1] Regional Development - The North China region has a high concentration of standard substance production, with 244 items approved from January to July, making up 44.4% of the total and showing a significant year-on-year increase of 165.2% [1] - Beijing leads in the number of approvals, showcasing regional characteristics where research institutions and enterprises leverage their advantages to enhance both quality and quantity [1] Future Directions - The National Market Regulation Administration plans to strengthen the capacity building for national standard substances and promote related production to support high-quality social development [1]
上半年新批准建立国家标准物质524项 同比增长78.8%
Ren Min Ri Bao· 2025-07-13 22:03
Core Insights - In the first half of this year, China approved the establishment of 524 national standard materials, representing a year-on-year increase of 78.8% [1] - The total number of approved national standard materials has reached 18,982, with the country maintaining a leading position in international measurement mutual recognition capabilities [1] Group 1: National Standard Materials Overview - National first-level standard materials accounted for 5.9% of the total, with 31 items approved, showing a year-on-year growth of 47.6% [1] - National second-level standard materials made up 94.1% of the total, with 493 items approved, reflecting a year-on-year increase of 81.3% [1] Group 2: Application Areas - In the environmental monitoring sector, 202 standard materials were approved, accounting for 38.6% of the total, with a year-on-year growth of 69.7% [2] - The manufacturing and petrochemical industries saw the approval of 150 standard materials, representing 28.6% of the total, with a significant year-on-year increase of 108.3% [2] - In the food and agricultural product safety testing sector, 134 standard materials were approved, making up 25.6% of the total, with a year-on-year growth of 78.6% [2] - The medical and health sector had 38 standard materials approved, accounting for 7.2% of the total, with a year-on-year increase of 40.7% [2] Group 3: Specific Developments - The newly approved EGFR gene mutation genomic DNA standard material is expected to enhance the quality of companion diagnostics for targeted therapy in non-small cell lung cancer, thereby improving treatment outcomes [1] - The newly established series of graphite physical property standard materials will provide precise and reliable testing benchmarks for lithium battery manufacturers, supporting raw material quality control and production process optimization [2]
我国上半年新批准建立国家标准物质524项
仪器信息网· 2025-07-10 08:19
Core Insights - In the first half of the year, China approved the establishment of 524 national standard materials, representing a year-on-year increase of 78.8%, involving 51 research units [2][3] - The total number of approved national standard materials has reached 18,982, with international metrology mutual recognition capabilities ranking in the top tier globally [5] Summary by Categories New Standard Materials - Among the 524 new standard materials, 31 are national first-level standards (5.9% of the total), with a year-on-year growth of 47.6%, while 493 are second-level standards (94.1%), showing an 81.3% increase [3] Application Areas - Environmental monitoring standards account for 202 items (38.6%), with a growth of 69.7% - Manufacturing and petrochemical industry standards total 150 items (28.6%), marking a significant increase of 108.3% - Food and agricultural product safety testing standards comprise 134 items (25.6%), with a year-on-year growth of 78.6% - Medical and health standards include 38 items (7.2%), reflecting a growth of 40.7% [4] Research Units - Enterprises submitted 379 standard materials (72.3%), with an increase of 86.7%, while research institutions submitted 145 items (27.7%), showing a growth of 61.1% - The majority of new standard materials are developed by enterprises, indicating a recovery in the economic vitality of the standard materials industry [5] Regional Distribution - North China leads with 234 new standard materials (44.7%), followed by East China with 124 items (23.7%) - Northeast China has 62 items (11.8%), Northwest China 48 items (9.2%), South China 32 items (6.1%), Southwest China 24 items (4.5%), and Central China has no new standard materials [5] Future Directions - The market regulatory authority plans to enhance the efficient supply of standard materials, focusing on emerging fields such as new materials and new energy, to support measurement technology innovation in manufacturing [5]
国家标准物质:1-6月新增524项,各领域增幅明显
Sou Hu Cai Jing· 2025-07-09 05:45
Core Insights - In the first half of this year, China approved 524 new national standard substances, marking a significant year-on-year increase of 78.8% [1] - The increase in approved standard substances indicates a recovery in industry vitality, with enterprises leading the submissions [1] Summary by Category Approval Statistics - A total of 524 national standard substances were approved, with 31 classified as national first-level standards (5.9% of total) and 493 as national second-level standards (94.1% of total) [1] - The first-level standards saw a year-on-year increase of 47.6%, while the second-level standards increased by 81.3% [1] Application Fields - Environmental monitoring received the highest number of approvals with 202 items (38.6% of total), reflecting a year-on-year increase of 69.7% [1] - The manufacturing and petrochemical industries accounted for 150 items (28.6% of total), with a substantial increase of 108.3% [1] - Food and agricultural product safety testing had 134 items (25.6% of total), increasing by 78.6% [1] - The medical and health sector received 38 items (7.2% of total), with a growth of 40.7% [1] Submissions by Type - Enterprises submitted 379 items (72.3% of total), showing an increase of 86.7% year-on-year [1] - Research institutions submitted 145 items (27.7% of total), with a year-on-year increase of 61.1% [1] Regional Distribution - The North China region led with 234 items (44.7% of total), followed by East China with 124 items (23.7%) [1] - Northeast China approved 62 items (11.8%), Northwest China 48 items (9.2%), South China 32 items (6.1%), Southwest China 24 items (4.5%), and Central China had no new approvals [1] - The North China region had the highest number of approvals, while the Southwest region showed the lowest growth rate [1] Future Directions - The State Administration for Market Regulation plans to enhance the supply of standard substances, focusing on emerging fields and promoting innovation in measurement technology within the manufacturing sector [1]
博晖创新收盘上涨2.07%,最新市净率3.52,总市值48.44亿元
Sou Hu Cai Jing· 2025-05-29 10:28
Group 1 - The core business of Beijing Bohui Innovation Biotechnology Group Co., Ltd. is the research, production, and sales of in vitro diagnostic products, including testing instruments, software, reagents, calibration products, quality control products, and national standard materials [1] - As of May 29, the company's stock closed at 5.93 yuan, with a 2.07% increase, a latest price-to-book ratio of 3.52, and a total market capitalization of 4.844 billion yuan [1] - The latest financial report for Q1 2025 shows the company achieved operating revenue of 202 million yuan, a year-on-year decrease of 23.05%, and a net profit of -4,054,437.18 yuan, a year-on-year decrease of 120.41%, with a gross profit margin of 38.37% [1] Group 2 - The company's price-to-earnings ratio (TTM) is -330.17, while the industry average is 49.64, indicating a significant underperformance compared to peers [2] - The company's market capitalization stands at 4.844 billion yuan, which is lower than the industry median of 4.928 billion yuan [2] - The company has a negative price-to-earnings ratio compared to other companies in the industry, such as Tianyi Medical and Aohua Endoscopy, which have ratios of -1776.29 and -644.66 respectively [2]